39
Views
22
CrossRef citations to date
0
Altmetric
Review

PET and the role of in vivo molecular imaging in personalized medicine

Pages 703-713 | Published online: 09 Jan 2014
 

Abstract

In order for personalized medicine to become a clinical reality a number of hurdles, both technological and regulatory in nature, need to be addressed. Our ability to image biological and pathological processes at a molecular level using positron emission tomography (PET) imaging offers an unparalleled opportunity to radically reform the manner in which a disease is diagnosed and managed. The degree to which current innovations in PET science will translate into clinical practice, thereby impacting upon personalized medicine, is discussed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.